Depression Treatment Pharmacology
Amino Acids
Treatment of
depression, as well as any other
monoamine neurotransmitter
diseases, is not possible
through the direct
administration of monoamine
neurotransmitters. This is due
to the fact that monoamine
neurotransmitters do not cross
the blood brain barrier, as
depicted in figure 1.2,3,4,5
The only way to increase the
levels of central nervous system
monoamine neurotransmitter
molecules is to provide amino
acid precursors, which cross the
blood brain barrier and are
synthesized into their
respective neurotransmitters by
pre-synaptic neurons.6,7
|
|
|
Depression Treatment Pharmacology
Amino Acids
Figure 1:
The monoamine neurotransmitters
serotonin, dopamine, norepinephrine, and
epinephrine do not cross the blood brain
barrier therefore peripheral
administration of these
neurotransmitters will not increase
central nervous system neurotransmitter
levels. The amino acid precursors of
these neurotransmitters do cross the
blood brain barrier. The only way to
increase central nervous system
neurotransmitter levels is through
administration of amino acid precursors.
Its no secret, NeuroResearch Clinics uses the nutrients 5-HTP, tyrosine, levodopa,
and cysteine to treat medical
patients in order to get these
results. Proper
use of these simple ingredients in
medical treatment is not simple.
From time to time a patient will
say, "Why do I want to take that, I
can go to a health food store and
buy it?" People off the street
buying in a health food store is
like going to an art store and
buying a bunch of oil paints then
going home and expecting to paint
like a mater artist even though
there was no previous painting
experience. These nutrients have
tremendous potential due to their
chemical properties. This potential
is only fully realized in the hands
of the trained professional using
neurotransmitter testing. Treatment
is not just giving a nutrient pill, it is the whole medical management approach doctors are trained in to insure that that treatment is on track in order to get symptoms under control.
The Peer Reviewed Research
of NeuroResearch Clinics
The neurotransmitter treatment research findings of NeuroResearch Clinics
have not been ignored. The University of
Minnesota Medical School is writing a series of
papers on the neurotransmitter testing research of NeuroResearch Clinics. The first of a series of papers by University of Minnesota Medical School based on the neurotransmitter testing research of NeuroResearch was published in "NeuroPsychiatric Disease and Treatment" May 1, 2009. Ingrid
Kohlstadt, MD of Johns Hopkins in her new
medical text book released February 7, 2009
included a chapter on depression written by
Marty L. Hinz, MD President Clinical
Research NeuroResearch Clinics outlining in
depth the proper use of amino acids and
neurotransmitter testing in treatment of
depression.
Depression Treatment Pharmacology
Amino Acids-research |
